Douglas, Gordon

Douglas, Gordon, M.D., former President, Merck Vaccine Division, Merck Co., Inc., telephone interview, Jime 5, 2001. 

Gaussian-1 theory A general procedure for prediction of molecular energies John A. Pople, Martin Head-Gordon, Douglas J. Fox, Krishnan Raghavachari and Larry A. Curtiss Journal of Chemical Physics 90 (1989) 5622-5629... 

Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Knott S, Ruane RJ, Xenobiotica 1991, 23,1243-1256. 

Goering, H.K., Gordon, C.H., Wrenn, T.R., Bitman, J, King, R.L., Douglas, F.W.. 1976. Effect of feeding protected safflower oil on yield, composition, flavor and oxidative stability of milk. J. Dairy Sci. 59, 416-425. 

Gordon Douglas claims he doesn t know how much it cost to finally develop the chickenpox vaccine, or any other vaccine he worked on at Merck, because he never totaled them up by product. You pay for the marketing, research, administrations, and all other costs as the costs are incurred, and therefore they are expensed against current sales, he says. 

For Charles Hyman and for Gordon Douglas, coming from the public sector and academia, respectively, the largesse in terms of supplies and support staff was overwhelming. If you needed something, you got it, Dr. Hyman recalled, still half-amazed, years later. My second day on the job, my secretary asked me, What do you need I was used to asking for 15 times what I needed, then add my Social Security number, and maybe I d get a third of that. So that s what he requested, more or less, at Merck. But this time, lo and behold, I come in the next day, and my desk was covered. 

Douglas P. Harrison / Gordon A. and Mary Cain Department of Chemical Engineering,... 

Clarkson, E.D., Gordon, R., Gundez, A., Douglas, A., Kelleher, C., Newkirk, K.T., Shutz, M.B., Schulz, S.M., Railer, R.F., and Washington, N., Cutaneous exposure to GD and VX timing of antidotes and decontamination, Proceedings ofthe 2004 Medical Defense Bioscience Review, Cutaneous Therapeutics, 150. 

I thank Dr Gordon Cragg of the Natural Products Branch at the NCI for helpful discussions and Professor Douglas Rivett and Dr Rob Keyzers for helpful editorial comments. Financial support from the South African National Research Foundation and the Department of Environmental Affairs and Tourism is gratefully acknowledged. 

Simon Melov, Joanne Ravenscroft, Sarwatt Malik, Matt S. Gill, David W. Walker, Peter E. Clayton, Douglas C. Wallace, Bernard Malfroy, Susan R. Doctrow and Gordon J. Lithgow, Extension of lifespan with superoxide dismutase/catalase mimetics. Science, 289 (2000), 1567-1569. 

Glynis Giddings, Gordon Allison, Douglas Brooks and Adrian Carter, Transgenic plants as factories for biopharmaceuticals. Nature Biotechnology, 18 (2000), 1151-1155. 

Breeii Robert, 146 Brooks, Harvey, 52, 54, 62, 132 Brown, Gordon S., 24, 179 Brown, J. Douglas, 27 Bucciarelli, Louis, 182 Buckley, William E, Jr., 102 Buhl, Harold R., 127 Burnham, Donald, 74 Burriss, Stanley W, 34, 96 Bush, Vannevai 29... 

Douglas SL, Daly BJ, Gordon N, et aL Survival and quality of life short-term versus longterm ventilator patients. Crit Care Med 2002 30(12) 2655-2662. 

---